Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

NUCLEIC ACID OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV 1) - ANVISA Registration 81752180017

Access comprehensive regulatory information for NUCLEIC ACID OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV 1) in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 81752180017 and manufactured by ALTONA DIAGNOSTICS GMBH. The registration is held by ALTONA DIAGNOSTICS BRASIL LTDA with validity until Jan 10, 2032.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 companies making the same product including CEPHEID AB, ABBOTT MOLECULAR INC, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Competitors
5 Recent Registrations
81752180017
2 Related Devices
Registration Details
ANVISA Registration Number: 81752180017
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Related Devices (2)

Registration Details

81752180017

25351383945202300

27669130000178

Company Information

Germany
PT: ALEMANHA

Dates and Status

Jul 10, 2023

10/01/2032

09/18/2025 19:00:01

Registration Details

81752180017

25351383945202300

27669130000178

Company Information

Dates and Status

Jul 10, 2023

10/01/2032

09/18/2025 19:00:01